Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Maculopathy,Age-related”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT07424235
What this trial is testing

Evaluating the Relationship Between Function and Structure Using Data From a GA Natural History Cohort

Who this might be right for
Age Related Macular Degeneration (AMD)Age Related Macular DegenerationAMD+3 more
IRCCS Ospedale San Raffaele 60
Not applicableEnded earlyNCT00347906
What this trial is testing

Photodynamic Therapy (PDT) Versus Transpupillary Thermotherapy (TTT) in Occult Choroidal Neovascularization (CNV) in Age-related Macular Degeneration (AMD)

Who this might be right for
Age-Related Macular Degeneration
University Hospital, Linkoeping
Very early researchStudy completedNCT03478878
What this trial is testing

Vitamin A Palmitate Supplementation in Patients With Reticular Pseudodrusen (RPD) and Delayed Dark Adaptation

Who this might be right for
Reticular Pseudodrusen (RPD)Age-Related Macular Degeneration
National Eye Institute (NEI) 9
Post-approval studies (Phase 4)UnknownNCT03205202
What this trial is testing

Cataract and AMD in a Trial of a Multivitamin and Cocoa Extract

Who this might be right for
CataractAge Related Macular Degeneration
Brigham and Women's Hospital 21,442
Not applicableStudy completedNCT02557451
What this trial is testing

Surgery, Tissue Plasminogen Activator, Antiangiogenic Agents and Age Related Macular Degeneration Complications

Who this might be right for
Subretinal Haematoma Linked to AMD
Centre Hospitalier Universitaire Dijon 91
Not applicableStudy completedNCT02540369
What this trial is testing

To Describe the Use of Intravitreal Aflibercept and to Describe Follow-up as Well as Treatment Patterns in Patients With Wet Age-related Macular Degeneration (wAMD) or Diabetic Macular Edema (DME) in Routine Clinical Practice in Canada.

Who this might be right for
Wet Macular Degeneration
Bayer 2,150
Large-scale testing (Phase 3)UnknownNCT02127463
What this trial is testing

Phase II/III Study of the Efficacy and Safety of MacuCLEAR MC-1101 in Treating DryAge-Related Macular Degeneration

Who this might be right for
Non-Exudative Age Related Macular Degeneration
MacuCLEAR, Inc. 60
Not applicableStudy completedNCT00088192
What this trial is testing

Intravitreous Pegaptanib Sodium Injection in Patients With Exudative Age-Related Macular Degeneration (AMD)

Who this might be right for
Macular Degeneration
Eyetech Pharmaceuticals
Large-scale testing (Phase 3)Study completedNCT05587062
What this trial is testing

Efficacy and Safety of Aflibercept in Patients With Neovascular Age-related Macular Degeneration

Who this might be right for
Age-Related Macular DegenerationNeovascular Age-related Macular Degeneration
Cinnagen 168
Large-scale testing (Phase 3)Study completedNCT03150589
What this trial is testing

Compare SB11 (Proposed Ranibizumab Biosimilar) to Lucentis in Subjects With Neovascular Age-related Macular Degeneration (AMD)

Who this might be right for
Age-Related Macular Degeneration
Samsung Bioepis Co., Ltd. 705
Not applicableUnknownNCT03061682
What this trial is testing

Implantation of Add on Lens for Age Related Macular Degeneration Patients With Low Vision

Who this might be right for
Inclusion Criteria
Rabin Medical Center 20
Large-scale testing (Phase 3)Study completedNCT04423718
What this trial is testing

Study of the Effects of High Dose Aflibercept Injected Into the Eye of Patients With an Age-related Disorder That Causes Loss of Vision Due to Growth of Abnormal Blood Vessels at the Back of the Eye

Who this might be right for
Neovascular Age-Related Macular Degeneration
Bayer 1,011
Testing effectiveness (Phase 2)Study completedNCT02358889
What this trial is testing

Study Evaluating Intravitreal hI-con1™ in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration

Who this might be right for
Choroidal NeovascularizationAge-related Macular Degeneration
Iconic Therapeutics, Inc. 88
Testing effectiveness (Phase 2)Study completedNCT00306488
What this trial is testing

OT-551 Antioxidant Eye Drops to Treat Geographic Atrophy in Age-Related Macular Degeneration

Who this might be right for
Geographic AtrophyAge-Related Macular DegenerationAMD
National Institutes of Health Clinical Center (CC) 11
Testing effectiveness (Phase 2)Ended earlyNCT02087085
What this trial is testing

A Safety and Efficacy Study of Brimonidine Intravitreal Implant in Geographic Atrophy Secondary to Age-related Macular Degeneration

Who this might be right for
Geographic AtrophyMacular Degeneration
Allergan 310
Testing effectiveness (Phase 2)Looking for participantsNCT07392255
What this trial is testing

An Optimised GA Interventional Trial (Opti-GAIN) to Test if Treatment With CTx001 is Safe and Works for People With Geographic Atrophy (GA)

Who this might be right for
Geographic Atrophy Secondary to Age-related Macular Degeneration
Complement Therapeutics 75
Not applicableLooking for participantsNCT01496625
What this trial is testing

National Eye Institute Biorepository for Retinal Diseases

Who this might be right for
Age-Related Macular DegenerationDiabetic RetinopathyVon Hippel-Lindau Syndrome+2 more
National Eye Institute (NEI) 650
Not applicableStudy completedNCT01644513
What this trial is testing

Evaluation of the Association Between Genetic Load and Response to Anti-VEGF Therapy in AMD Patients

Who this might be right for
Age Related Macular Degeneration
Sequenom, Inc. 196
Large-scale testing (Phase 3)Active Not RecruitingNCT06556368
What this trial is testing

Evaluate the Efficacy and Safety of Tarcocimab Tedromer and Tabirafusp Tedromer Compared to Aflibercept in Participants With Neovascular (Wet) Age-related Macular Degeneration (wAMD) - DAYBREAK

Who this might be right for
Wet Age-related Macular Degeneration
Kodiak Sciences Inc 675
Large-scale testing (Phase 3)Study completedNCT03386474
What this trial is testing

Study of Safety and Efficacy of Brolucizumab 6 mg Drug Product Intended for Commercialization in Patients With nAMD

Who this might be right for
Neovascular Age-related Macular Degeneration
Novartis Pharmaceuticals 151
Next Page